Immunology Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - Immunology Case Reports (2023) Volume 6, Issue 4

Natural immunogenic I-Ab-restricted antigen human immune system

Daniel Bug*

Department of Internal Medicine and Faculty of Medicine, University of Geneva, Geneva, Switzerland

*Corresponding Author:
Daniel Bug
Department of Internal Medicine and Faculty of Medicine
University of Geneva
Geneva, Switzerland
E-mail:danielbug@hcuge.ch

Received:26-July-2023, Manuscript No. AAICR-23-109017; Editor assigned:28-Jul-2023, PreQC No. AAICR-23-109017(PQ); Reviewed:11-Aug-2023, QC No. AAICR-23-109017; Revised:16-Aug-2023, Manuscript No. AAICR-23-109017(R); Published:23-Aug-2023, DOI:10.35841/aaicr-6.4.162

Citation: Bug D. Natural immunogenic I-Ab-restricted antigen human immune system. Immunol Case Rep. 2023;6(4):162

Visit for more related articles at Immunology Case Reports

Introduction

The immune system is a remarkable defense mechanism that protects our bodies from harmful pathogens and foreign invaders. Central to its function are antigen-presenting cells (APCs) that display fragments of foreign substances, called antigens, on their surface. These antigens are then recognized by T cells, triggering an immune response. One crucial group of antigens is known as I-Ab-restricted antigens, which have gained significant attention in immunology due to their unique properties and implications in disease immunity. In this article, we will delve into the concept of natural immunogenic I-Ab-restricted antigens, their importance, and their role in the immune response [1].

Understanding I-ab-restricted antigens

I-Ab-restricted antigens are a specific type of major histocompatibility complex class II (MHC II) molecules. MHC II molecules are expressed on the surface of professional APCs, such as dendritic cells, macrophages, and B cells. These molecules play a crucial role in the adaptive immune response by presenting antigens to CD4+ T helper cells. The I-Ab designation indicates a specific allele of the MHC II molecule found in certain mouse strains. In other organisms, similar alleles are referred to with different designations. In humans, for instance, HLA-DRB1 is an analogous MHC II allele [2].

Immunogenicity of I-ab-restricted antigens

Immunogenicity refers to an antigen's ability to provoke an immune response. I-Ab-restricted antigens are considered immunogenic due to their capacity to elicit an immune reaction in the presence of appropriate T cell receptors (TCRs). Upon encountering an I-Ab-restricted antigen, CD4+ T cells with TCRs that specifically recognize the antigen-MHC II complex become activated. These activated T cells, in turn, trigger an orchestrated immune response, recruiting other immune cells to eliminate the perceived threat [3].

Natural I-Ab-restricted antigens are endogenous peptides derived from intracellular proteins of the host organism. These antigens are generated through the process of antigen processing and presentation. When cells undergo normal metabolic processes, intracellular proteins are degraded into smaller peptides. These peptides are then loaded onto MHC II molecules in the endosomal-lysosomal compartments of APCs. The MHC II-antigen complex is subsequently presented on the cell surface, where CD4+ T cells can recognize them [4].

I-Ab-restricted antigens play a pivotal role in several aspects of the immune response and disease immunity. Some key points of significance includes in certain autoimmune diseases, self-antigens are mistakenly recognized as foreign, leading to an immune attack against the body's tissues. Understanding I-Ab-restricted antigens and their presentation may provide insights into the mechanisms behind autoimmune disorders and potential therapeutic targets. In vaccine development, selecting the right antigens that efficiently stimulate a protective immune response is crucial. Studying I-Ab-restricted antigens may aid researchers in identifying potent vaccine candidates for specific pathogens. I-Ab-restricted antigens also have implications in cancer immunology. Tumor cells may present unique antigens derived from mutated proteins, and CD4+ T cell responses to these antigens could potentially enhance anti-tumor immune responses [5].

Conclusion

Natural immunogenic I-Ab-restricted antigens represent a captivating area of study in immunology. Their role in the immune response, disease immunity, and potential therapeutic applications make them a subject of ongoing research. By furthering our understanding of these antigens and their interactions with the immune system, we may unlock new avenues for immunotherapy, vaccine development, and treatments for various diseases, ultimately leading to better health outcomes for individuals around the world.

References

  1. Vita R, Overton JA, Greenbaum JA, et al. The immune epitope database (IEDB) 3.0. Nucleic acids research. 2015;43(D1):D405-12.

    2. Indexed at, Google Scholar, Cross Ref

  2. Tungatt K, Bianchi V, Crowther MD, et al. Antibody stabilization of peptide–MHC multimers reveals functional T cells bearing extremely low-affinity TCRs. J Immunol. 2015;194(1):463-74.

    3. Indexed at, Google Scholar,Cross Ref

  3. Tubo NJ, Pagán AJ, Taylor JJ, et al. Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection. Cell. 2013;153(4):785-96.

    4. Indexed at, Google Scholar, Cross Ref

  4. Watts RA, Isenberg DA. Autoantibodies and antibacterial antibodies: from both sides now. Ann Rheum Dis. 1990;49(12):961.

    5. Indexed at, Google Scholar, Cross Ref

  5. Turunen SP, Kummu O, Harila K, et al. Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein. . PloS one. 2012;7(4):e34910.

    6. Indexed at, Google Scholar, Cross Ref

Get the App